Home » Topics » Regulatory

Regulatory
RSS

FDA approves Androgel for treatment of hypogonadism

March 2, 2000

No Comments

AstraZeneca files sNDA with FDA for Casodex 150 mg

March 1, 2000

No Comments

Santen seeks FDA approval of levofloxacin for bacterial conjunctivitis

March 1, 2000

No Comments

FDA approves new Allegra formulations

March 1, 2000

No Comments

Nycomed Amersham receives approvable letter for extended use of Myoview

Feb. 29, 2000

No Comments

Angiotech announces promising results from phase I/II SPMS study

Feb. 29, 2000

No Comments

Extended-release metformin shows good phase I results

Feb. 28, 2000

No Comments

Allergan and Dura enter commercialization agreement for multiple products

Feb. 25, 2000

No Comments

Use of FK-506 as topical analgesic disclosed

Feb. 25, 2000

No Comments

Nastech's intranasal apomorphine compared to Viagra in phase II pilot trial

Feb. 25, 2000

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Regulatory
RSS

FDA approves Androgel for treatment of hypogonadism

AstraZeneca files sNDA with FDA for Casodex 150 mg

Santen seeks FDA approval of levofloxacin for bacterial conjunctivitis

FDA approves new Allegra formulations

Nycomed Amersham receives approvable letter for extended use of Myoview

Angiotech announces promising results from phase I/II SPMS study

Extended-release metformin shows good phase I results

Allergan and Dura enter commercialization agreement for multiple products

Use of FK-506 as topical analgesic disclosed

Nastech's intranasal apomorphine compared to Viagra in phase II pilot trial

Today's news in brief

Today's news in brief

Enhanced Cognition: Lewy body dementia phase II pumps stock

Experimental mRNA gene therapy suppresses preeclampsia in mice

Probing bidirectional cancer-autoimmune link can yield new targets

Regulatory RSS

Regulatory
RSS